Sunshine Biopharma Inc. Disposal Group, Including Discontinued Operation, Revenue
Sunshine Biopharma Inc. (SBFM) reported Disposal Group, Including Discontinued Operation, Revenue of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Income Statement › Other Income
us-gaap:DisposalGroupIncludingDiscontinuedOperationRevenue · last filed 2021-03-30
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for the quarter ending 2020-12-31 was $0.00.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for fiscal 2019 was $81.92K, a 71.28% decline from fiscal 2018.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, revenue for fiscal 2018 was $285.21K.
| Period end | Disposal Group, Including Discontinued Operation, Revenue 3 month | Disposal Group, Including Discontinued Operation, Revenue 3 month as first filed | Disposal Group, Including Discontinued Operation, Revenue 6 month | Disposal Group, Including Discontinued Operation, Revenue 9 month | Disposal Group, Including Discontinued Operation, Revenue 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | -$37.60K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | -$37.60K derived: sum of 3 quarters · filed 2021-03-30 | $81.92K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | -$37.60K derived: sum of 2 quarters · filed 2021-03-30 | $81.92K derived: sum of 3 quarters · filed 2021-03-30 | $201.44K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2019-12-31 | -$37.60K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $81.92K derived: sum of 2 quarters · filed 2021-03-30 | $201.44K derived: sum of 3 quarters · filed 2021-03-30 | $81.92K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $119.52K 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2019-11-13 | $239.04K derived: sum of 2 quarters · filed 2020-11-12 | $119.52K 10-Q · filed 2020-11-12 | $308.42K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $119.52K 10-Q/A · filed 2020-08-31 | $0.00 10-Q · filed 2019-08-15 | $119.52K 10-Q/A · filed 2020-08-31 | $188.90K derived: sum of 3 quarters · filed 2020-08-31 | $325.84K derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $119.52K 10-Q · filed 2020-05-18 | $69.38K derived: sum of 2 quarters · filed 2020-05-18 | $206.31K derived: sum of 3 quarters · filed 2020-05-18 | $313.56K derived: sum of 4 quarters · filed 2020-05-18 | |
| 2018-12-31 | -$50.15K derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $86.79K derived: sum of 2 quarters · filed 2020-05-01 | $194.04K derived: sum of 3 quarters · filed 2020-05-01 | $285.21K 10-K · filed 2020-05-01 | |
| 2018-09-30 | $136.94K 10-Q · filed 2019-11-13 | $244.19K derived: sum of 2 quarters · filed 2019-11-13 | $335.36K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $107.25K 10-Q · filed 2019-08-15 | $198.42K 10-Q · filed 2019-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |